The synthesis of bisphosphonate analogues of nucleotides – derivatives of (α-phenyl)(α-fluoro)methylenebisphosphonic acids
DOI:
https://doi.org/10.24959/ophcj.14.824Keywords:
bisphosphonates, 1, 2, 3-triazoles, nucleozides, nucleotides, furanozidesAbstract
The synthetic methods of fluorine-containing mimetics of nucleozide-diphosphates based on the derivatives of (α-fluoro)(α-phenyl) methylenebisphosphonic acid containing the residues of 2-{1-[4-(toluene-4-sulfonyl)-5-per-fluoroalkyl-[1,2,3]triazol-2-yl]-ethoxy}-ethelene and {2,2-dimethyl-6-[4(toluene-4-sulfonyl)-5-pentafluoroethyl-[1,2,3] triazol-2-yl]-tetrahyro-furo[3,4-d][1,3]dioxol-4-yl}-methylene as ester groups have been developed. Selective mono-and bisdealkylation of methoxy-groups in the tetramethyl ester of (α-fluoro)(α-phenyl)methylenebisphosphonic acid allows to prepare in high yields the corresponding trimethyl or symmetrical dimethyl esters containing one or two free reactive phosphonic acids groups. These compounds are convenient starting materials for the synthesis of mixed esters of (α-fluoro)(α-phenyl)methylenebisphosphonic acid by esterefication of acidic functionalities using simple aliphatic alcohols (n-butanol) and such analogues of nucleosides as 2-{1-[4-(toluene-4-sulfonyl)-5-perfluoroalkyl-[1,2,3]triazol-2-yl]-ethoxy}-ethanols and {2,2-dimethyl-6-[4(toluene-4-sulfonyl)-5-pentafluoroethyl-[1,2,3]triazol-2-yl]-tetrahyro-furo[3,4-d][1,3]dioxol-4-yl}-methanol. The structure of the compounds obtained has been proven using the methods of IR, NMR (1H, 13C, 19F, 31P) spectroscopy, mass-spectra, and elemental analysis. The cytotoxicity and antiviral activity of the compounds synthesized have been studied on the model of the Epstein-Barr virus. The compound possessing a significant inhibitory effect on the Epstein-Barr virus reproduction has been found.
Downloads
References
- Wagner C. R., Iyer V. V., McIntee E. J. Medicinal Research Reviews, 2000, Vol. 20, No.6, pp.417-451.
- Jones R. J., Bischofberger N. Antiviral Research, 1995, Vol. 1-2, No.27, pp.1-17.
- Perigaud C., Girardet J.-L., Gosselin G., Imbach J.-L. Advances in Antiviral Drug Design, 1995, Vol. 2, pp.147-172.
- Bonnaffé D., Dupraz B., Ughetto-Monfrin J., Namane A., Henin Y., Dinh T. M. J. of Organic Chem., 1996, Vol. 3, No.61, pp.895-902.
- Engel R. Chem. Rev., 1977, Vol. 3, No.77, pp.349-367.
- Ma Q.-F., Bathurst I. C., Barr P. J., Kenyon G. L. J. of Med. Chem., 1992, Vol. 11, No.35, pp.1938-1941.
- Li R., Muscate A., Kenyon G. L. Bioorg. Chem., 1996, Vol. 3, No.24, pp.251-261.
- Shipitsin A. V., Victorova L. S., Shirokova E. A., Dyatkina N. B., Goryunova L. E., Beabealashvilli R. Sh., Hamilton C. J., Roberts S. M., Krayevsky A. J. of the Chemical Society, Perkin Transactions 1, 1999, No.8, pp.1039-1050.
- Yanachkov I., Wright G. E. Nucleosides, Nucleotides & Nucleic Acids, 1994, Vol. 1-3, No.13, pp.339-350.
- Kanishchev O. S., Gudz G. P., Shermolovich Yu. G., Zagorodnya S. D., Golovan A. V., Kurova A. O., Nesterova N. V. Zhurnal organichnoi ta farmatsevtichnoi khimii – Journal of organic and pharmaceutical chemistry, 2012, Vol. 10, No.1, pp.30-37.
- Guzyr O. I., Zasukha S. V., Vlasenko S. V., Chernega A. N., Rozhenko A. B., Shermolovich Yu. G. Europian Journal of Inorganic Chemistry, 2013, No.24, pp.4154-4158.
- Kanishchev O. S., Timoshenko V. M., But S. A., Chernega A. N., Shermolovich Yu. G. Zhurnal organichnoi ta farmatsevtichnoi khimii – Journal of organic and pharmaceutical chemistry, 2008, Vol. 6, No.4, pp.65-70.
- Kanishchev O. S., Gudz G. P., Shermolovich Yu. G., Nesterova N. V., Zagorodnya S. D., Golovan A. V. Nucleosides, Nucleotides & Nucleic Acids, 2011, Vol. 10, No.30, pp.768-783.
- Bello A. M., Poduch E., Fujihashi M., Amani M., Li Y., Crandall I., Hui R., Lee P. I., Kain K. C., Pai E. F., Kotra L. P. Journal of Medicinal Chemistry, 2007, Vol. 5, No.50, pp.915-921.
- Greene T. W., Wuts P. G. M., Protective groups in organic synthesis, John Wiley & Sons, 1991.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2014 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:
1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.
3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).